Recombinant Monkey TNFRSF4 Protein (Leu29-Ala216), C-hFc-tagged
Product Description
Cat
IMP-9579
Official Symbol
TNFRSF4
Product Overview
Recombinant Cynomolgus OX40/TNFRSF4 protein (Leu29-Ala216) with a Human IgG1 (Pro100-Lys330) Fc tag at C-terminus was expressed in Human embryonic kidney cell.
Description
The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor has been shown to activate NF-kappaB through its interaction with adaptor proteins TRAF2 and TRAF5. Knockout studies in mice suggested that this receptor promotes the expression of apoptosis inhibitors BCL2 and BCL2lL1/BCL2-XL, and thus suppresses apoptosis. The knockout studies also suggested the roles of this receptor in CD4+ T cell response, as well as in T cell-dependent B cell proliferation and differentiation.
Expression System
HEK293
Species
Monkey
Tag
C-hFc
Predicted N Terminal
Leu29
Form
Lyophilized from a 0.2 μm filtered solution in PBS with trehalose.
Molecular Mass
Predicted Molecular Mass: 47 kDa
SDS-PAGE: 62-72 kDa, under reducing conditions
Protein length
Leu29-Ala216
Bio-activity
Measured by its binding ability in a functional ELISA. When Recombinant Human OX40 Ligand/TNFSF4 is immobilized at 250 ng/mL, the concentration of Recombinant Cynomolgus Monkey OX40/TNFRSF4 Fc Chimera that produces 50% optimal binding response is found to be approximately 5-30 ng/mL.
Endotoxin
<0.10 EU/μg of the protein by the LAL method.
Purity
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie Blue Staining.
Notes
Disulfide-linked homodimer
Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
12 months from date of receipt, -20 to -70 centigrade as supplied.
1 month, 2 to 8 centigrade under sterile conditions after reconstitution.
3 months, -20 to -70 centigrade under sterile conditions after reconstitution.
Reconstitution
Reconstitute at 200 μg/mL in PBS.
SDS-PAGE
SDS-PAGE

Bioactivity-ELISA 1
Binding Activity

Measured by its binding ability in a functional ELISA. When Recombinant Human OX40 Ligand/TNFSF4 is immobilized at 250 ng/mL, the concentration of Recombinant Cynomolgus Monkey OX40/TNFRSF4 Fc Chimera that produces 50% optimal binding response is found to be approximately 5-30 ng/mL.

Data Sheet MSDS
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.

Online Inquiry
Contact Info